Market Research Report
Aesthetic Medicine Global Market Report 2022
|Aesthetic Medicine Global Market Report 2022|
The Business Research Company
Content info: 175 Pages
Delivery time: 2-10 business days
“Aesthetic Medicine Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global aesthetic medicine market.
This report focuses on aesthetic medicine market which is experiencing strong growth. The report gives a guide to the aesthetic medicine market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Where is the largest and fastest growing market for the aesthetic medicine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Aesthetic Medicine market global report” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider aesthetic medicine market, and compares it with other markets.
Major players in the aesthetic medicine market are: Allergan Plc, Alma Lasers, Cutera, Cynosure, Galderma, Galderma Laboratories, Johnson & Johnson, Lumenis, Merz Pharmaceuticals, Solta Medical, AbbVie, Syneron Candela, El.En. S.p.A., Dentsply Sirona Inc, Evolus, Fotona d.o.o., Medytox Inc, GC Aesthetics, Sientra, and Skin Tech Pharma Group.
The global aesthetic medicine market is expected to grow from $51.60 billion in 2021 to $56.73 billion in 2022 at a compound annual growth rate (CAGR) of 9.94%. The aesthetic medicine market is expected to grow to $82.87 billion in 2026 at a compound annual growth rate (CAGR) of 9.94%.
The aesthetic medicine market consists of sales of aesthetic medicine by entities (organizations, sole traders, and partnerships) that refer to non-invasive and minimally invasive devices and instruments, designed to perform procedures focused on improving the physical appearance and satisfaction of the patient. The medical aesthetic treatments carried out through these aesthetic medicine products include non-invasive lipolysis, hair restoration & removal, cellulite reduction, wrinkle reduction, skin renewal & resurfacing, and others.
The main products of aesthetic medicine include facial aesthetic products, body contouring devices, cosmetic implants, hair removal devices, skin aesthetic devices, tattoo removal devices, thread lift products, physician-dispensed cosmeceuticals and skin lighteners, physician-dispensed eyelash products, and nail treatment laser devices. The facial aesthetic refers to the products used in facial aesthetics treatments and procedures. Facial aesthetics consists of a range of non-surgical treatments performed on the face, which includes botox, fillers, and anti-wrinkle injections. The types of procedures in aesthetic medicine includes invasive procedures and non-invasive procedures. They are used in clinics, hospitals, and medical spas, beauty centres, and home care units.
North America was the largest region in the aesthetic medicine market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aesthetic medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The aesthetic medicine market research report is one of a series of new reports from The Business Research Company that provides aesthetic medicine market statistics, including aesthetic medicine industry global market size, regional shares, competitors with a aesthetic medicine market share, detailed aesthetic medicine market segments, market trends and opportunities, and any further data you may need to thrive in the aesthetic medicine industry. This aesthetic medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The growing obese populations across the globe is expected to propel the growth of the aesthetic medicine market. The increase in unhealthy food consumption, lack of physical activity, and parental & postnatal influences are contributing to rapid growth in the obese population across the globe. Individuals with obesity, seek aesthetic medicine for fat reduction, meso/face-lift, and other benefits through various invasive and non-invasive aesthetic medicine procedures. For instance, in 2019, according to a European health interview survey on the overweight or obese population in Europe conducted by Eurostat, the statistical office of the European Union, reported that 52.7% of the adult population of Europe was overweight. Therefore, the growing number of obese populations across the globe is expected to drive the growth of the aesthetic medicine market.
New product development for a wide spectrum of skin types is a key trend in the aesthetic medicine market. Aesthetic medicine companies are focusing on launching new products and solutions to cater to the needs of various skin types and expand their customer reach. These products can be used in the treatment and patient care for a broad spectrum of skin types resulting in a wider application range. For instance, in September 2020, Allergan Aesthetics, an American pharmaceutical company, and Skinbetter Science, a US-based skincare company launched the DREAM initiative (DREAM: Driving Racial Equity in Aesthetic Medicine). This will help in the development of new products for all kinds of racial and ethnic groups so that aesthetic providers can meet the needs of all patients. In addition, in March 2020, Galderma, a Swiss pharmaceutical company announced to make significant investments to grow its aesthetic portfolio, including digital enhancements to ASPIRE Galderma Rewards.
In May 2020, AbbVie, an American biopharmaceutical company acquired Allergan for USD 63 billion. This acquisition is expected to diversify AbbVie's portfolio and create cost efficiency in R&D commercialization activities. Allergan is an American developer and manufacturer of aesthetic medicines and other products.
The countries covered in the aesthetic medicine market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.